Table 1 Patients’ baseline characteristics (n = 64)
Age (years) | 63 ± 8 |
Women, n (%) | 32 (50) |
Diabetes duration (years) | 9 ± 8 |
Smoking habit, n (%) | 34 (53) |
Past history of cardiovascular diseases, n (%) | 0 (0) |
Family history of cardiovascular diseases, n (%) | 26 (41) |
Systolic blood pressure (mmHg) | 128 ± 13 |
Diastolic blood pressure (mmHg) | 76 ± 6 |
Hypertension, n (%) | 41 (64) |
Dyslipidemia, n (%) | 42 (66) |
Obesity, n (%) | 28 (44) |
Diabetic complications, n (%) | 16 (25) |
Use of anti-hypertensive therapies | |
Beta-blockers, n (%) | 21 (33) |
Angiotensin-converting enzyme inhibitors, n (%) | 15 (23) |
Calcium entry blockers, n (%) | 12 (23) |
Diuretics, n (%) | 20 (31) |
Use of lipid-lowering drugs | |
Statins, n (%) | 26 (41) |
Fibrates, n (%) | 9 (14) |
Omega-3 fatty acids, n (%) | 12 (19) |
Aspirin use, n (%) | 8 (13) |